SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-046944
Filing Date
2022-04-18
Accepted
2022-04-18 17:16:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm228771d3_defa14a.htm DEFA14A 15913
  Complete submission text file 0001104659-22-046944.txt   16890
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39044 | Film No.: 22832799
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences